Although somewhat challenging to directly compare the relative magnitude of incretin signalling induced benefits with the current data, it does appear that Ac3IV has equivalent, if not superior, efficacy than liraglutide or sitagliptin in terms of limiting beta-cell transdifferentaition in diabetes [10]. Here, GCG is linked to diabetes mellitus.